Thanks to the rapidly evolving integration of LLMs into decision-support tools, a significant transformation is happening across large-scale systems. Like other medical fields, the use of LLMs such as GPT-4 is gaining increasing interest in radiation oncology as well. An attempt to assess GPT-4's performance in radiation oncology was made via a dedicated 100-question examination on the highly specialized topic of radiation oncology physics, revealing GPT-4's superiority over other LLMs. GPT-4's performance on a broader field of clinical radiation oncology is further benchmarked by the ACR Radiation Oncology In-Training (TXIT) exam where GPT-4 achieved a high accuracy of 74.57%. Its performance on re-labelling structure names in accordance with the AAPM TG-263 report has also been benchmarked, achieving above 96% accuracies. Such studies shed light on the potential of LLMs in radiation oncology. As interest in the potential and constraints of LLMs in general healthcare applications continues to rise5, the capabilities and limitations of LLMs in radiation oncology decision support have not yet been fully explored.
Mathematical oncology is an interdisciplinary research field where the mathematical sciences meet cancer research. Being situated at the intersection of these two fields makes mathematical oncology highly dynamic, as practicing researchers are incentivised to quickly adapt to both technical and medical research advances. Determining the scope of mathematical oncology is therefore not straightforward; however, it is important for purposes related to funding allocation, education, scientific communication, and community organisation. To address this issue, we here conduct a bibliometric analysis of mathematical oncology. We compare our results to the broader field of mathematical biology, and position our findings within theoretical science of science frameworks. Based on article metadata and citation flows, our results provide evidence that mathematical oncology has undergone a significant evolution since the 1960s marked by increased interactions with other disciplines, geographical expansion, larger research teams, and greater diversity in studied topics. The latter finding contributes to the greater discussion on which models different research communities consider to be valuable
Recent advances in large language models (LLMs) and their extension to vision-language models (VLMs) have made it easier to combine text and images for tasks such as report generation. Existing VLMs in medicine typically focus on 2D images (chest X-rays), and their extension to 3D imaging has been difficult because of the lack of paired 3D imaging-text data. Thus, we introduce a new method for creating a 3D image-text dataset for brain oncology using 3D MRI scans of glioma and meningioma cases. We use a cooperative system in which several LLMs work together to generate and check reports, ensuring that they are accurate and clear. By leveraging the new 3D MRI-text dataset, we further build a VLM that converts MRI scans into tokens and aligns them with text instructions. Our VLM performed better in report generation and visual question answering tasks than other 2D and 3D methods. Our method not only improves the quality of reports but also helps with better diagnosis and treatment in brain oncology.
Personalized oncology aims to tailor treatment strategies to the unique molecular and clinical profiles of individual patients, moving beyond the traditional paradigm of treating the disease not the patient. Achieving this vision requires the integration and interpretation of vast, heterogeneous biomedical data within a meaningful scientific framework. Knowledge graphs, structured according to biomedical ontologies, offer a powerful approach to contextualize and interconnect diverse datasets, enabling more precise and informed clinical decision-making. We present ECKO (Explainable Clinical Knowledge for Oncology), a comprehensive knowledge graph that integrates 33 biomedical ontologies and aggregates data from multiple studies to create a unified resource optimized for data-driven clinical applications in oncology. Designed to support personalized drug recommendations, ECKO facilitates the identification of optimal therapeutic options by linking patient-specific molecular data to relevant pharmacological knowledge. It provides transparent, interpretable explanations for drug recommendations, fostering greater trust and understanding among clinicians and researchers. This resource r
We present the Radiation Oncology NLP Database (ROND), the first dedicated Natural Language Processing (NLP) dataset for radiation oncology, an important medical specialty that has received limited attention from the NLP community in the past. With the advent of Artificial General Intelligence (AGI), there is an increasing need for specialized datasets and benchmarks to facilitate research and development. ROND is specifically designed to address this gap in the domain of radiation oncology, a field that offers many opportunities for NLP exploration. It encompasses various NLP tasks including Logic Reasoning, Text Classification, Named Entity Recognition (NER), Question Answering (QA), Text Summarization, and Patient-Clinician Conversations, each with a distinct focus on radiation oncology concepts and application cases. In addition, we have developed an instruction-tuning dataset consisting of over 20k instruction pairs (based on ROND) and trained a large language model, CancerChat. This serves to demonstrate the potential of instruction-tuning large language models within a highly-specialized medical domain. The evaluation results in this study could serve as baseline results for
Cancer evolves continuously over time through a complex interplay of genetic, epigenetic, microenvironmental, and phenotypic changes. This dynamic behavior drives uncontrolled cell growth, metastasis, immune evasion, and therapy resistance, posing challenges for effective monitoring and treatment. However, today's data-driven research in oncology has primarily focused on cross-sectional analysis using data from a single modality, limiting the ability to fully characterize and interpret the disease's dynamic heterogeneity. Advances in multiscale data collection and computational methods now enable the discovery of longitudinal multimodal biomarkers for precision oncology. Longitudinal data reveal patterns of disease progression and treatment response that are not evident from single-timepoint data, enabling timely abnormality detection and dynamic treatment adaptation. Multimodal data integration offers complementary information from diverse sources for more precise risk assessment and targeting of cancer therapy. In this review, we survey methods of longitudinal and multimodal modeling, highlighting their synergy in providing multifaceted insights for personalized care tailored to
The emergence of artificial general intelligence (AGI) is transforming radiation oncology. As prominent vanguards of AGI, large language models (LLMs) such as GPT-4 and PaLM 2 can process extensive texts and large vision models (LVMs) such as the Segment Anything Model (SAM) can process extensive imaging data to enhance the efficiency and precision of radiation therapy. This paper explores full-spectrum applications of AGI across radiation oncology including initial consultation, simulation, treatment planning, treatment delivery, treatment verification, and patient follow-up. The fusion of vision data with LLMs also creates powerful multimodal models that elucidate nuanced clinical patterns. Together, AGI promises to catalyze a shift towards data-driven, personalized radiation therapy. However, these models should complement human expertise and care. This paper provides an overview of how AGI can transform radiation oncology to elevate the standard of patient care in radiation oncology, with the key insight being AGI's ability to exploit multimodal clinical data at scale.
In the era of targeted therapy, there has been increasing concern about the development of oncology drugs based on the "more is better" paradigm, developed decades ago for chemotherapy. Recently, the US Food and Drug Administration (FDA) initiated Project Optimus to reform the dose optimization and dose selection paradigm in oncology drug development. To accommodate this paradigm shifting, we propose a dose-ranging approach to optimizing dose (DROID) for oncology trials with targeted drugs. DROID leverages the well-established dose-ranging study framework, which has been routinely used to develop non-oncology drugs for decades, and bridges it with established oncology dose-finding designs to optimize the dose of oncology drugs. DROID consists of two seamlessly connected stages. In the first stage, patients are sequentially enrolled and adaptively assigned to investigational doses to establish the therapeutic dose range (TDR), defined as the range of doses with acceptable toxicity and efficacy profiles, and the recommended phase 2 dose set (RP2S). In the second stage, patients are randomized to the doses in RP2S to assess the dose-response relationship and identify the optimal dose.
Mechanistic learning, the synergistic combination of knowledge-driven and data-driven modeling, is an emerging field. In particular, in mathematical oncology, the application of mathematical modeling to cancer biology and oncology, the use of mechanistic learning is growing. This review aims to capture the current state of the field and provide a perspective on how mechanistic learning may further progress in mathematical oncology. We highlight the synergistic potential of knowledge-driven mechanistic mathematical modeling and data-driven modeling, such as machine and deep learning. We point out similarities and differences regarding model complexity, data requirements, outputs generated, and interpretability of the algorithms and their results. Then, organizing combinations of knowledge- and data-driven modeling into four categories (sequential, parallel, intrinsic, and extrinsic mechanistic learning), we summarize a variety of approaches at the interface between purely data- and knowledge-driven models. Using examples predominantly from oncology, we discuss a range of techniques including physics-informed neural networks, surrogate model learning, and digital twins. We see that m
Nowadays, the increase in patient demand and the decline in resources are lengthening patient waiting times in many chemotherapy oncology departments. Therefore, enhancing healthcare services is necessary to reduce patient complaints. Reducing the patient waiting times in the oncology departments represents one of the main goals of healthcare manager. Simulation models are considered an effective tool for identifying potential ways to improve patient flow in oncology departments. This paper presents a new agent-based simulation model designed to be configurable and adaptable to the needs of oncology departments which have to interact with an external pharmacy. When external pharmacies are utilized, a courier service is needed to deliver the individual therapies from the pharmacy to the oncology department. An oncology department located in southern Italy was studied through the simulation model and different scenarios were compared with the aim of selecting the department configuration capable of reducing the patient waiting times.
Artificial intelligence (AI) is about to touch every aspect of radiotherapy from consultation, treatment planning, quality assurance, therapy delivery, to outcomes modeling. There is an urgent need to train radiation oncologists and medical physicists in data science to help shepherd AI solutions into clinical practice. Poorly trained personnel may do more harm than good when attempting to apply rapidly developing and complex technologies. As the amount of AI research expands in our field, the radiation oncology community needs to discuss how to educate future generations in this area. The National Cancer Institute (NCI) Workshop on AI in Radiation Oncology (Shady Grove, MD, April 4-5, 2019) was the first (https://dctd.cancer.gov/NewsEvents/20190523_ai_in_radiation_oncology.htm) of two data science workshops in radiation oncology hosted by the NCI in 2019. During this workshop, the Training and Education Working Group was formed by volunteers among the invited attendees. Its members represent radiation oncology, medical physics, radiology, computer science, industry, and the NCI. In this perspective article written by members of the Training and Education Working Group, we provide
We report new constraints on the spin-dependent scattering cross section between low-mass dark matter and protons using data collected by the COSINE-100 experiment. By implementing a specialized event selection process using a multi-layer perceptron and robust noise mitigation, this analysis pioneers a detection threshold of 3 and 4 isolated peaks, corresponding to the reconstructed photoelectrons, which are significantly lower than the 8 photoelectron threshold used in previous analyses. In this unstudied few-photoelectron regime, where instrumental noise and phosphorescence are prevalent, we utilize a phenomenological background model to search for the annual modulation signal expected from the Standard Halo Model. No statistically significant annual modulation is observed in our data. We derive new 90% confidence level (C.L.) upper limits for the spin-dependent DM-proton cross section, establishing the world's most stringent constraints in the 1.75-2.25 GeV/c$^2$ mass range. Furthermore, by incorporating the Migdal effect, we extend the experimental sensitivity to the sub-GeV/c$^2$ regime, setting world-leading limits in the 15-58 MeV/c$^2$ range. These results demonstrate the c
This paper presents a magnet-based robotic skin that integrates a multilayer soft lattice with distributed Hall-effect sensor arrays and a tactile super-resolution model. External contact forces are converted to magnetic field changes by embedded permanent magnets, and the lattice spreads these changes across the sensing domain. This gives each sensor a large, overlapping receptive field and enables a large sensing area with minimal blind spots. Lattice parameters are tunable, enabling joint adjustment of mechanical compliance and transduction characteristics. An implicit modeling workflow and selective laser sintering (SLS) 3D printing support rapid fabrication of conformal, high-complexity structures. A convolutional neural network trained on experimental measurements estimates contact location and normal force in real time. Experiments validate localization accuracy and indicate scalability to larger surfaces, suggesting applicability to whole-body robotic skin and safe human-robot interaction.
Watermarking should identify language-model output without degrading quality or limiting verification to the model provider. Multilingual deployment makes this harder because morphology, segmentation, and script change where watermark evidence can enter naturally. We introduce LUNA, a linguistically adaptive watermark that combines model-free detection with single-token non-distortion under the standard random-key model. LUNA estimates normalized next-tag entropy from part-of-speech contexts in an external corpus and uses it to set the depth of a non-distortionary binary tournament sampler; the detector reconstructs the same schedule from text, a tokenizer, a tagger, and a secret key. We evaluate six typologically diverse languages and two domains against eight primary baselines. LUNA attains an AUROC of 0.9959 and the lowest mean absolute median perplexity shift of 0.045 across the twelve settings; its 95% bootstrap interval [0.022, 0.073] lies below all baseline intervals. LUNA also records the lowest mean Self-BLEU, Distinct-1, surprisal, and entropy shifts. It is the only method that simultaneously achieves AUROC > 0.99 and an absolute median perplexity shift below 0.1 in a
Precision oncology tests that profile tumors to identify clinically actionable targets have rapidly entered clinical practice. Effective visual presentation of the results of these tests is crucial in accurate clinical decision-making. In current practice, these results are typically delivered to oncologists as static prints, who then incorporate them into their clinical decision-making process. However, due to a lack of guidelines for standardization, different vendors use different report formats. There is very little known on the effectiveness of these report formats or the criteria necessary to improve them. In this study, we have aimed to identify both the tasks and the needs of oncologists from precision oncology report design and then to improve the designs based on these findings. To this end, we report results from multiple interviews and a survey study (n=32) conducted with practicing oncologists. Based on these results, we compiled a set of design criteria for precision oncology reports and developed a prototype report design using these criteria, along with feedback from oncologists.
COVID-19 outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduced in the ICH E9 addendum. We propose strategies to handle COVID-19 related intercurrent events, depending on their relationship with malignancy and treatment and the interpretability of data after them. We argue that the clinical trial objective from a world without COVID-19 pandemic remains valid. The estimand framework provides a common language to discuss the impact of COVID-19 in a structured and transparent manner. This demonstrates that the applicability of the framework may even go beyond what it was initially intended for.
We present results of the search for sub-GeV dark matter interaction with electrons in the NaI(Tl) crystals of the COSINE-100 experiment. The two benchmark scenarios of a heavy and a light vector boson as mediator of the interaction were studied. We found no excess events over the expected background in a data-set of 2.82 years, with a total exposure of 172.9 kg-year. The derived 90% confidence level upper limits exclude a DM-electron scattering cross section above 6.4 $\times$ 10$^{-33}$ cm$^2$ for a DM mass of 0.25 GeV, assuming a light mediator; and above 3.4 $\times$ 10$^{-37}$ cm$^2$ for a 0.4 GeV DM, assuming a heavy mediator, and represent the most stringent constraints for a NaI(Tl) target to date. We also briefly discuss a planned analysis using an annual modulation method below the current 0.7 keV threshold of COSINE-100, down to few photoelectrons yield.
The presence of Non-Line-of-Sight (NLoS) blind spots resulting from roadside parking in urban environments poses a significant challenge to road safety, particularly due to the sudden emergence of pedestrians. mmWave technology leverages diffraction and reflection to observe NLoS regions, and recent studies have demonstrated its potential for detecting obscured objects. However, existing approaches predominantly rely on predefined spatial information or assume simple wall reflections, thereby limiting their generalizability and practical applicability. A particular challenge arises in scenarios where pedestrians suddenly appear from between parked vehicles, as these parked vehicles act as temporary spatial obstructions. Furthermore, since parked vehicles are dynamic and may relocate over time, spatial information obtained from satellite maps or other predefined sources may not accurately reflect real-time road conditions, leading to erroneous sensor interpretations. To address this limitation, we propose an NLoS pedestrian localization framework that integrates monocular camera image with 2D radar point cloud (PCD) data. The proposed method initially detects parked vehicles through
The JSNS2-II (the second phase of JSNS2, J-PARC Sterile Neutrino Search at J-PARC Spallation Neutron Source) is an experiment aimed at searching for sterile neutrinos. This experiment has entered its second phase, employing two liquid scintillator detectors located at near and far positions from the neutrino source. Recently, the far detector of the experiment has been completed and is currently in the calibration phase. This paper presents a detailed description of the calibration process utilizing the LED system. The LED system of the far detector uses two Ultra-Violet (UV) LEDs, which are effective in calibrating all of PMTs at once. The UV light is converted into the visible light wavelengths inside liquid scintillator via the wavelength shifters, providing pseudo-isotropic light. The properties of all functioning Photo-Multiplier-Tubes (PMTs) to detect the neutrino events in the far detector, such as gain, its dependence of supplied High Voltage (HV), and Peak-to-Valley (PV) were calibrated. To achieve a good energy resolution for physics events, up to 10% of the relative gain adjustment is required for all functioning PMTs. This will be achieved using the measured HV curves a
The annual modulation signal, claimed to be consistent with dark matter as observed by DAMA/LIBRA in a sodium-iodide based detector, has persisted for over two decades. COSINE-100 and ANAIS-112 were designed to test the claim directly using the same target material. COSINE-100, located at Yangyang Underground Laboratory in South Korea, and ANAIS-112, located at Canfranc Underground Laboratory in Spain, have been taking data since 2016 and 2017, respectively. Each experiment published its respective results independently. In this paper, we present the results of an annual modulation search as a test of the signal observed by DAMA/LIBRA with the first three respective years of data from COSINE-100 and ANAIS-112. Using a Markov Chain Monte Carlo method, we find best fit values for modulation amplitude of $-0.0002 {\pm} 0.0026$ cpd/kg/keV in the 1-6 keV and $0.0021 {\pm} 0.0028$ cpd/kg/keV in the 2-6 keV energy regions. These results are not compatible with DAMA/LIBRA's assertion for their observation of annual modulation at $3.7σ$ and $2.6σ$, respectively. Performing a simple combination of the newly released 6-years datasets from both experiments find values consistent with no modula